98%
921
2 minutes
20
Background: Leadless pacemakers have transformed pacing by reducing risk for infection and lead-related complications. The feasibility of achieving leadless Bachmann's bundle area pacing (BBAP) for atrial resynchronization is not known.
First-in-human Summary: A 49-year-old woman with sinus node dysfunction and interatrial conduction delay underwent leadless atrial pacemaker targeting Bachmann's bundle (BB). Using intracardiac echocardiography and electrographic mapping, the pacemaker was positioned at the BB region. Reduced right atrium-to-lateral left atrium conduction time and paced P wave duration were confirmed.
Discussion: Right atrial appendage pacing may exacerbate interatrial conduction delay and promote atrial fibrillation. BBAP using a leadless atrial pacemaker, in contrast, has been shown to enhance atrial synchrony.
Novelty: This case demonstrates the first-in-human permanent implantation of a leadless pacemaker in the BB area, providing a strategy for leadless atrial resynchronization.
Take-home Message: Leadless BBAP may offer a physiological approach to atrial conduction system pacing by improving atrioventricular dromotropy and reducing subsequent risk for atrial fibrillation.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jaccas.2025.104083 | DOI Listing |
Heart Rhythm O2
August 2025
Department of Cardiology, Triemli Hospital Zürich, Zürich, Switzerland.
Background: Leadless pacemakers (LPs) can reduce long-term complications compared with conventional devices. However, previous studies have primarily focused on single chamber right ventricular LPs.
Objective: This study aimed to evaluate the implantation, safety, and device performance characteristics in a first real-world European use of an active fixation atrial LP for either dual chamber or single chamber pacing.
Rev Esp Cardiol (Engl Ed)
August 2025
Servicio de Cardiología, Instituto Cardiovascular del Hospital Clínico San Carlos, Fundación para la Investigación Biomédica del Hospital Clínico San Carlos (IDISCC), Madrid, España; Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Instituto de Salud Carl
Introduction: This report presents data on cardiac pacing system implants in Spain during 2024.
Methods: The registry is based on data voluntarily submitted by implanting centers to the Heart Rhythm Association of the Spanish Society of Cardiology via the national online platform, CardioDispositivos. Additional data sources included: a) data provided by device manufacturers and distributors, b) the European pacemaker patient card, and c) local databases submitted by implanting centers.
Kyobu Geka
August 2025
Department of Cardiovascular Surgery, Yonemori Hospital, Kagoshima, Japan.
A 74-year-old man was implanted with a permanent pacemaker for sick sinus syndrome ten years earlier and permanent atrial fibrillation( AF). Echocardiography indicated progressive severe tricuspid regurgitation (TR) and right ventricular systolic dysfunction with tricuspid annular dilatation and tricuspid valve tethering. The pacemaker lead passing through the tricuspid valve may have contributed to TR, therefore we decided to perform tricuspid valve surgery, pacemaker lead removal, and leadless pacemaker implantation simultaneously during open heart surgery.
View Article and Find Full Text PDFIntern Med
August 2025
Department of Cardiology, Nagoya University Graduate School of Medicine, Japan.
Objective Unlike transvenous lead pacemakers (TVPs), leadless pacemakers (LPs) do not require a subcutaneous pocket in the chest or transvenous lead. This makes LPs a favorable option, particularly for elderly patients. However, clear criteria have not yet been established for choosing between TVP and LP.
View Article and Find Full Text PDFHeart Rhythm
July 2025
Division of Electrophysiology, Heart and Vascular Institute, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania. Electronic address: